Skip to content

Exploratory Study of Hyperbaric Oxygen Therapy for Post-acute Sequelae of SARS-CoV-2 Infection

Exploratory Study of Hyperbaric Oxygen Therapy for Post-acute Sequelae of SARS-CoV-2 Infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082032
Enrollment
Unknown
Registered
2024-03-19
Start date
2024-03-25
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-acute Sequelae of SARS-CoV-2 Infection

Interventions

Hyperbaric Oxygen Therapy Group:The hyperbaric oxygen treatment group will receive treatment for 2 weeks or more, 5 times per week for 2 hours, using 2 ATA.
Conventional Oxygen Therapy Group:Conventional e oxygen therapy, such as nasal catheter oxygen therapy, should be taken according to the advice of clinicians and their own conditions

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Confirmed cases in Beijing Municipality that meet the diagnostic criteria outlined in the "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 10)", and have subsequently recovered. 2. The participant or their authorized representative understands the purpose of the entire study, voluntarily agrees to participate, and signs the informed consent form. 3. Agrees to the collection of clinical samples.

Exclusion criteria

Exclusion criteria: 1. Under 18 years of age; 2. Suffering from chronic obstructive pulmonary disease (COPD), pneumothorax, pleurisy, labyrinthitis or otitis media, epilepsy; 3. Currently experiencing acute respiratory tract infections; Suffering from life-threatening cardiovascular diseases, such as uncontrolled hypertension, myocardial infarction, etc.; 4. Suffering from mental illness; Suffering from claustrophobia; 5. Pregnant or lactating women; 6. Refusing to participate in regular assessments.

Design outcomes

Primary

MeasureTime frame
Improvement in Organ Dysfunction;Laboratory test;

Secondary

MeasureTime frame
Improvement in Immune Profiles Associated with Organ Dysfunction in Post-COVID-19 Patients Treated with Hyperbaric Oxygen Therapy;The Multiomics Characteristics Associated with Improvement of Organ Dysfunction in Post-COVID-19 Patients Treated with Hyperbaric Oxygen;High-resolution CT of the chest;

Countries

China

Contacts

Public ContactTong Zhaohui

Beijing Chaoyang Hospital, Capital Medical University

tongzhaohuicy@sina.com+86 139 1093 0309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026